News | May 18, 2011

First Wisconsin Center Implants LAA Occluders to Prevent Stroke in Afib Patients


May 18, 2011 - Jasbir Sra, M.D., and Tanvir Bajwa, M.D., are the first in Wisconsin to implant a new device in a patient’s heart that may reduce strokes in individuals suffering from atrial fibrillation, a common heart arrhythmia. This minimally invasive procedure was part of a clinical trial taking place at Aurora St. Luke’s Medical Center.

Developed by Atritech Inc., the device is designed to eliminate the use of blood thinners in patients suffering from atrial fibrillation, a condition that increases the risk of stroke because of blood clots. Currently, blood thinners like warfarin or Coumadin, which are used to prevent clotting, present health risks themselves and impact a patient’s quality of life – particularly in patients over the age of 65.

The new device, known as the Watchman, is implanted via catheter into the left atrial appendage of the heart, a location where it is thought that most blood clots originate in patients with atrial fibrillation. The device closes off this appendage, which prevents blood clots from escaping and entering the blood stream.

Aurora St. Luke’s Medical Center is the only health care provider in Wisconsin participating in the PREVAIL clinical trial, which will continue for the next five years.

The placement of these devices requires cooperation and collaboration between multiple specialties and caregivers, and marks a potential new era in the treatment of patients with atrial fibrillation.

For more information: www.aurorahealthcare.org/facilities/display.asp?ID=0001


Related Content

News | Stroke

May 11, 2023 — Adults in their 20s and 30s with mental disorders have an up to three-fold elevated likelihood of a heart ...

Home May 11, 2023
Home
News | Stroke

May 8, 2023 — Researchers of the Cellular and Molecular Neurobiology (CMN) Research Group at the Germans Trias i Pujol ...

Home May 08, 2023
Home
News | Stroke

April 24, 2023 — -RapidAI, a global leader in neurovascular and vascular AI-enhanced clinical decision support and ...

Home April 24, 2023
Home
News | Stroke

March 15, 2023 — Many patients don’t receive much rehabilitation therapy following a stroke, despite strong evidence ...

Home March 15, 2023
Home
News | Stroke

February 21, 2023 — Strokes are a leading cause of morbidity and mortality in the United States, as well as around the ...

Home February 21, 2023
Home
News | Stroke

February 20, 2023 — A novel Stroke Preclinical Assessment Network (SPAN) identified potential neuroprotective effects ...

Home February 20, 2023
Home
News | Stroke

February 16, 2023 — According to an accepted manuscript published in ARRS’ American Journal of Roentgenology (AJR) ...

Home February 16, 2023
Home
News | Stroke

February 15, 2023 — Thrombolysis use increased from 4% in 2010 to 14% in 2020 in the traditionally underserved urban ...

Home February 15, 2023
Home
News | Stroke

February 14, 2023 — VST-Bio Corp. a leader in the development of innovative biologics to treat acute and chronic ...

Home February 14, 2023
Home
News | Stroke

February 14, 2023 — A large international clinical study finds that patients with large strokes had a dramatically ...

Home February 14, 2023
Home
Subscribe Now